Strata Critical Medical, Inc.
SRTA· Nasdaq
Filed Aug 16, 2021 · 10-Q · 47 days after period end · 0001104659-21-105544
| Metric | Q2 2021 | Q2 2020 |
|---|---|---|
| Revenue | $12.95M | $3.44M |
| Net Income | -$24.29M | -$5.98K |
| EPS Diluted | -$0.47 | -$0.01 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Strata Critical Medical, Inc. · CIK 1779128 · Engraved from SEC EDGAR
ended Jun 30, 2021 · filed Aug 16, 2021 · 47 d after period end